These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3743910)

  • 1. Mechanisms of antisecretory action of intragastric FPL-52694: a mast cell stabilizer in anesthetized rats.
    Takeuchi K; Ueki S; Okabe S
    Digestion; 1986; 34(4):259-67. PubMed ID: 3743910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of gastric acid secretion in the conscious dog by the mast-cell stabilizing agent, FPL 52694.
    Canfield SP; Curwain BP
    Br J Pharmacol; 1983 Sep; 80(1):27-32. PubMed ID: 6652372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
    Okabe S; Shimosako K; Amagase K
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric juice electrolyte secretion in conscious dogs with gastric fistulae and its modification by FPL 52694, a mast cell stabilizing agent.
    Canfield SP; Curwain BP
    Br J Pharmacol; 1983 Nov; 80(3):451-7. PubMed ID: 6357336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoprotective action of mast cell stabilizers against ethanol-induced gastric lesions in rats.
    Takeuchi K; Nishiwaki H; Okabe S
    Jpn J Pharmacol; 1986 Oct; 42(2):297-307. PubMed ID: 3099041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of two mast cell stabilising agents and verapamil on rat gastric acid secretion in vitro.
    Canfield P; Coruzzi G; Curwain B; Rundell T
    Eur J Pharmacol; 1985 Oct; 116(1-2):89-95. PubMed ID: 3932083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of FPL-52694, a new mast cell stabilizer, on gastric secretion and various acute gastric lesions in rats.
    Takeuchi K; Ishihara Y; Kunimi H; Okabe S
    Agents Actions; 1984 Jun; 14(5-6):637-42. PubMed ID: 6540973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of ethanol-induced gastric damage by sodium cromoglycate and FPL-52694. Role of leukotrienes, prostaglandins, and mast cells in the protective mechanism.
    Beck PL; Morris GP; Wallace JL
    Can J Physiol Pharmacol; 1989 Apr; 67(4):287-93. PubMed ID: 2503242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of endogenous prostaglandins by mild hyperosmotic saline inhibits tetragastrin-stimulated gastric acid secretion in rats.
    Suzuki Y; Harada Y; Ueno A; Katori M; Okabe H
    Prostaglandins; 1986 Sep; 32(3):401-14. PubMed ID: 3466230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of FPL 52694 on gastric acid secretion in the healthy human stomach.
    Reimann HJ; Schmidt U; Ultsch B; Sullivan TJ; Wendt P
    Gut; 1984 Nov; 25(11):1221-4. PubMed ID: 6500362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nitric oxide in pathogenesis of aspirin-induced gastric mucosal damage in rats.
    Takeuchi K; Yasuhiro T; Asada Y; Sugawa Y
    Digestion; 1998; 59(4):298-307. PubMed ID: 9693199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastric acid secretion with a mast cell stabiliser, FPL-52694.
    Davies HA; Rhodes J; Thomas M
    Br J Clin Pharmacol; 1981 Jan; 11(1):53-6. PubMed ID: 7213509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topical application of KT1-32 on transmucosal potential difference and acid secretion in the rat stomach.
    Takeuchi K; Tanaka T; Wakabayashi S; Mochizuki S; Tomiyama A; Okabe S
    Jpn J Pharmacol; 1990 Oct; 54(2):227-35. PubMed ID: 2077187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of locally-applied capsaicin on distension-stimulated gastric acid secretion in the anesthetized rat.
    Barrachina MD; Martinez-Cuesta MA; Canet A; Esplugues JV; Esplugues J
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Dec; 346(6):685-90. PubMed ID: 1484566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of gastric acid secretion in conscious dog with fistula following intragastric administration of FPL 52694.
    Curwain BP; Canfield SP
    Int J Tissue React; 1983; 5(3):245-7. PubMed ID: 6654623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of irritative activity of compound 48/80 on rat gastric mucosa.
    Takeuchi K; Ohtsuki H; Nobuhara Y; Okabe S
    Digestion; 1986; 33(1):34-44. PubMed ID: 3940236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide in regulation of gastric acid secretion in rats: effects of NO donors and NO synthase inhibitor.
    Kato S; Kitamura M; Korolkiewicz RP; Takeuchi K
    Br J Pharmacol; 1998 Mar; 123(5):839-46. PubMed ID: 9535011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous prostaglandins in gastric alkaline response in the rat stomach after damage.
    Takeuchi K; Ueki S; Tanaka H
    Am J Physiol; 1986 Jun; 250(6 Pt 1):G842-9. PubMed ID: 3459368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a mast cell stabiliser (FPL 52694) on human gastric secretion.
    Boyd EJ; Wilson JA; Wormsley KG; Richards MH; Langman MJ
    Agents Actions; 1985 Sep; 16(6):462-7. PubMed ID: 4072827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
    Isobe Y; Nagai H; Muramatsu M; Aihara H; Otomo S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1078-82. PubMed ID: 1979811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.